{"transactions":[{"id":4622707,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"common stock","published_at":"2026-09-18T17:42:38.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":434451,"price":3.28,"value":1424999.28,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Matlin purchased 434,451 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended."}],"balance_after":912275,"source":{"system":"sec-edgar","filing":"0001437749-26-030730","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926030730/rdgdoc.xml","form_type":"4"}},{"id":4622706,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":37998,"kind":"person","name":"Etherington Robert Dee","position":1,"cik":"0001835330","reported_name":"Etherington Robert Dee","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"common stock","published_at":"2026-09-18T17:41:42.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":15244,"price":3.28,"value":50000.32,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Etherington purchased 15,244 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer.  The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended."}],"balance_after":55393,"source":{"system":"sec-edgar","filing":"0001437749-26-030729","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835330/000143774926030729/rdgdoc.xml","form_type":"4"}},{"id":4622704,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"ten_percent_owner":true}}],"security":"common stock","published_at":"2026-09-18T17:40:17.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":198171,"price":3.28,"value":650000.88,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Kensington Clene 2021, LLC purchased 198,171 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC.  Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC.  The securities owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca.  Ms. Mosca disclaims all securities owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":478671,"source":{"system":"sec-edgar","filing":"0001437749-26-030728","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835537/000143774926030728/rdgdoc.xml","form_type":"4"}},{"id":687079,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23410,"kind":"person","name":"Kiernan Matthew","position":1,"cik":"0001993183","reported_name":"Kiernan Matthew","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:32:44.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":3195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 3,195 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":3195,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":3195},"source":{"system":"sec-edgar","filing":"0001437749-26-027973","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993183/000143774926027973/rdgdoc.xml","form_type":"4"}},{"id":686422,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":20726,"kind":"person","name":"Desai Arjun JJ","position":1,"cik":"0001982985","reported_name":"Desai Arjun JJ","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:32:05.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":3674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 3,674 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":3674,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":3674},"source":{"system":"sec-edgar","filing":"0001437749-26-027971","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926027971/rdgdoc.xml","form_type":"4"}},{"id":686421,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:31:25.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":4872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 4,872 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":4872,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":4872},"source":{"system":"sec-edgar","filing":"0001437749-26-027970","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926027970/rdgdoc.xml","form_type":"4"}},{"id":686635,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:30:42.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":6230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 6,230 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":6230,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":6230},"source":{"system":"sec-edgar","filing":"0001437749-26-027968","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926027968/rdgdoc.xml","form_type":"4"}},{"id":686420,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23204,"kind":"person","name":"Jacobovitz Shalom","position":1,"cik":"0001835556","reported_name":"Jacobovitz Shalom","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:29:56.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":4752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 4,752 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":4752,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":4752},"source":{"system":"sec-edgar","filing":"0001437749-26-027967","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926027967/rdgdoc.xml","form_type":"4"}},{"id":687005,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23375,"kind":"person","name":"Gay Jonathon","position":1,"cik":"0001835422","reported_name":"Gay Jonathon","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:28:55.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":3794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 3,794 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":3794,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":3794},"source":{"system":"sec-edgar","filing":"0001437749-26-027966","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835422/000143774926027966/rdgdoc.xml","form_type":"4"}},{"id":687060,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23398,"kind":"person","name":"McLaughlin Vallerie","position":1,"cik":"0001876030","reported_name":"McLaughlin Vallerie","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:28:08.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":3514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":3514,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":3514},"source":{"system":"sec-edgar","filing":"0001437749-26-027965","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876030/000143774926027965/rdgdoc.xml","form_type":"4"}},{"id":686651,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23299,"kind":"person","name":"WILCOX REED N","position":1,"cik":"0001266609","reported_name":"WILCOX REED N","relationship":{"director":true}}],"security":"stock option","published_at":"2026-08-14T19:27:27.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":3514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant."}],"balance_after":3514,"derivative":{"exercise_price":4.19,"expiration_date":"2036-08-12","underlying":"common stock","underlying_shares":3514},"source":{"system":"sec-edgar","filing":"0001437749-26-027964","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266609/000143774926027964/rdgdoc.xml","form_type":"4"}},{"id":693838,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant ($4.82 strike)","published_at":"2026-08-06T17:32:16.000Z","date":"2026-07-17","kind":"other","planned":false,"acquired":false,"shares":424358,"ownership":{"direct":false,"nature":"By SymBiosis II LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the \"Fund\") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable"}],"balance_after":0,"derivative":{"exercise_price":4.82,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":424358},"source":{"system":"sec-edgar","filing":"0001835544-26-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000022/primary_doc.xml","form_type":"4"}},{"id":693837,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock (Tranche B, $30.00 strike)","published_at":"2026-08-06T17:32:16.000Z","date":"2026-07-17","kind":"other","planned":false,"acquired":false,"shares":375000,"ownership":{"direct":false,"nature":"By SymBiosis II LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the \"Fund\") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable"}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001835544-26-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000022/primary_doc.xml","form_type":"4"}},{"id":737917,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38213,"kind":"person","name":"Mortenson Mark","position":1,"cik":"0001835427","reported_name":"Mortenson Mark","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"stock option","published_at":"2026-06-15T18:24:17.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2026 as an option for 45,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share.  The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested."}],"balance_after":45000,"derivative":{"exercise_price":5.53,"expiration_date":"2036-06-10","underlying":"common stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-26-020637","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835427/000143774926020637/rdgdoc.xml","form_type":"4"}},{"id":737335,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":37998,"kind":"person","name":"Etherington Robert Dee","position":1,"cik":"0001835330","reported_name":"Etherington Robert Dee","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"stock option","published_at":"2026-06-15T18:23:25.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2026 as an option for 65,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share.  The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested."}],"balance_after":65000,"derivative":{"exercise_price":5.53,"expiration_date":"2036-06-10","underlying":"common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001437749-26-020636","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926020636/rdgdoc.xml","form_type":"4"}},{"id":737630,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"stock option","published_at":"2026-06-15T18:22:39.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2026 as an option for 15,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share.  The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested."}],"balance_after":15000,"derivative":{"exercise_price":5.53,"expiration_date":"2036-06-10","underlying":"common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-26-020635","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000143774926020635/rdgdoc.xml","form_type":"4"}},{"id":766233,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23398,"kind":"person","name":"McLaughlin Vallerie","position":1,"cik":"0001876030","reported_name":"McLaughlin Vallerie","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T18:03:40.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":2064,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":2064},"source":{"system":"sec-edgar","filing":"0001437749-26-018221","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1876030/000143774926018221/rdgdoc.xml","form_type":"4"}},{"id":766232,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23398,"kind":"person","name":"McLaughlin Vallerie","position":1,"cik":"0001876030","reported_name":"McLaughlin Vallerie","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T18:03:40.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018221","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876030/000143774926018221/rdgdoc.xml","form_type":"4"}},{"id":765252,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":20726,"kind":"person","name":"Desai Arjun JJ","position":1,"cik":"0001982985","reported_name":"Desai Arjun JJ","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T18:02:42.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 2,158 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":2158,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":2158},"source":{"system":"sec-edgar","filing":"0001437749-26-018220","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926018220/rdgdoc.xml","form_type":"4"}},{"id":765251,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":20726,"kind":"person","name":"Desai Arjun JJ","position":1,"cik":"0001982985","reported_name":"Desai Arjun JJ","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T18:02:42.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018220","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926018220/rdgdoc.xml","form_type":"4"}},{"id":765255,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T18:02:03.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 2,861 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":2861,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":2861},"source":{"system":"sec-edgar","filing":"0001437749-26-018219","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926018219/rdgdoc.xml","form_type":"4"}},{"id":765254,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T18:02:03.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018219","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926018219/rdgdoc.xml","form_type":"4"}},{"id":765644,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:58:34.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":3659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 3,659 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":3659,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":3659},"source":{"system":"sec-edgar","filing":"0001437749-26-018218","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926018218/rdgdoc.xml","form_type":"4"}},{"id":765643,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:58:34.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018218","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926018218/rdgdoc.xml","form_type":"4"}},{"id":765250,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23204,"kind":"person","name":"Jacobovitz Shalom","position":1,"cik":"0001835556","reported_name":"Jacobovitz Shalom","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:57:45.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 2,791 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":2791,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":2791},"source":{"system":"sec-edgar","filing":"0001437749-26-018217","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926018217/rdgdoc.xml","form_type":"4"}},{"id":765249,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23204,"kind":"person","name":"Jacobovitz Shalom","position":1,"cik":"0001835556","reported_name":"Jacobovitz Shalom","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:57:45.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018217","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926018217/rdgdoc.xml","form_type":"4"}},{"id":766284,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23410,"kind":"person","name":"Kiernan Matthew","position":1,"cik":"0001993183","reported_name":"Kiernan Matthew","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:55:33.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 1,876 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":1876,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1876},"source":{"system":"sec-edgar","filing":"0001437749-26-018216","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993183/000143774926018216/rdgdoc.xml","form_type":"4"}},{"id":766283,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23410,"kind":"person","name":"Kiernan Matthew","position":1,"cik":"0001993183","reported_name":"Kiernan Matthew","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:55:33.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018216","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993183/000143774926018216/rdgdoc.xml","form_type":"4"}},{"id":766113,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23375,"kind":"person","name":"Gay Jonathon","position":1,"cik":"0001835422","reported_name":"Gay Jonathon","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:54:50.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 2,228 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":2228,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":2228},"source":{"system":"sec-edgar","filing":"0001437749-26-018215","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835422/000143774926018215/rdgdoc.xml","form_type":"4"}},{"id":766112,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23375,"kind":"person","name":"Gay Jonathon","position":1,"cik":"0001835422","reported_name":"Gay Jonathon","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:54:50.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018215","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835422/000143774926018215/rdgdoc.xml","form_type":"4"}},{"id":765650,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23299,"kind":"person","name":"WILCOX REED N","position":1,"cik":"0001266609","reported_name":"WILCOX REED N","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:53:50.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":2064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant."}],"balance_after":2064,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":2064},"source":{"system":"sec-edgar","filing":"0001437749-26-018214","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266609/000143774926018214/rdgdoc.xml","form_type":"4"}},{"id":765649,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23299,"kind":"person","name":"WILCOX REED N","position":1,"cik":"0001266609","reported_name":"WILCOX REED N","relationship":{"director":true}}],"security":"stock option","published_at":"2026-05-22T17:53:50.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested."}],"balance_after":1500,"derivative":{"exercise_price":6.81,"expiration_date":"2036-05-20","underlying":"common stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-26-018214","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266609/000143774926018214/rdgdoc.xml","form_type":"4"}},{"id":780296,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T22:04:05.000Z","date":"2026-05-12","kind":"sale","planned":false,"acquired":false,"shares":73296,"price":6.2,"value":454435.2,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":103417,"source":{"system":"sec-edgar","filing":"0001835544-26-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000019/primary_doc.xml","form_type":"4"}},{"id":780295,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T22:04:05.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":22177,"price":6.75,"value":149694.75,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":176713,"source":{"system":"sec-edgar","filing":"0001835544-26-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000019/primary_doc.xml","form_type":"4"}},{"id":791049,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T21:53:45.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":72884,"price":6.8,"value":495611.2,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":198890,"source":{"system":"sec-edgar","filing":"0001835544-26-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000018/primary_doc.xml","form_type":"4"}},{"id":791048,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T21:53:45.000Z","date":"2026-05-01","kind":"sale","planned":false,"acquired":false,"shares":5795,"price":6.01,"value":34827.95,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":271774,"source":{"system":"sec-edgar","filing":"0001835544-26-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000018/primary_doc.xml","form_type":"4"}},{"id":796565,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T21:54:39.000Z","date":"2026-04-30","kind":"sale","planned":false,"acquired":false,"shares":5736,"price":6.08,"value":34874.88,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":277569,"source":{"system":"sec-edgar","filing":"0001835544-26-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000017/primary_doc.xml","form_type":"4"}},{"id":796564,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T21:54:39.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":12170,"price":5.63,"value":68517.1,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":283305,"source":{"system":"sec-edgar","filing":"0001835544-26-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000017/primary_doc.xml","form_type":"4"}},{"id":796563,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T21:54:39.000Z","date":"2026-04-28","kind":"sale","planned":false,"acquired":false,"shares":1591,"price":5.9,"value":9386.9,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":295475,"source":{"system":"sec-edgar","filing":"0001835544-26-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000017/primary_doc.xml","form_type":"4"}},{"id":802401,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T21:55:36.000Z","date":"2026-04-21","kind":"sale","planned":false,"acquired":false,"shares":61345,"price":6.14,"value":376658.3,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":297066,"source":{"system":"sec-edgar","filing":"0001835544-26-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000016/primary_doc.xml","form_type":"4"}},{"id":802400,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T21:55:36.000Z","date":"2026-04-20","kind":"sale","planned":false,"acquired":false,"shares":4318,"price":6.12,"value":26426.16,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":358411,"source":{"system":"sec-edgar","filing":"0001835544-26-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000016/primary_doc.xml","form_type":"4"}},{"id":805024,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-18T00:17:12.000Z","date":"2026-04-17","kind":"sale","planned":false,"acquired":false,"shares":25040,"price":6.43,"value":161007.2,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":362729,"source":{"system":"sec-edgar","filing":"0001835544-26-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000015/primary_doc.xml","form_type":"4"}},{"id":805023,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-18T00:17:12.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":7748,"price":6.4,"value":49587.2,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":387769,"source":{"system":"sec-edgar","filing":"0001835544-26-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000015/primary_doc.xml","form_type":"4"}},{"id":805022,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-18T00:17:12.000Z","date":"2026-04-15","kind":"sale","planned":false,"acquired":false,"shares":6374,"price":6.48,"value":41303.52,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":395517,"source":{"system":"sec-edgar","filing":"0001835544-26-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000015/primary_doc.xml","form_type":"4"}},{"id":814093,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-06T21:32:25.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":24925,"price":4.81,"value":119889.25,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":401891,"source":{"system":"sec-edgar","filing":"0001835544-26-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000014/primary_doc.xml","form_type":"4"}},{"id":822388,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:10:37.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":4278,"price":4.97,"value":21261.66,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":426816,"source":{"system":"sec-edgar","filing":"0001835544-26-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000013/primary_doc.xml","form_type":"4"}},{"id":823871,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T20:35:07.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":67991,"price":4.88,"value":331796.08,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":431094,"source":{"system":"sec-edgar","filing":"0001835544-26-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000012/primary_doc.xml","form_type":"4"}},{"id":823870,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T20:35:07.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":15536,"price":5.1,"value":79233.6,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":499085,"source":{"system":"sec-edgar","filing":"0001835544-26-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000012/primary_doc.xml","form_type":"4"}},{"id":823869,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T20:35:07.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":17470,"price":4.75,"value":82982.5,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":514621,"source":{"system":"sec-edgar","filing":"0001835544-26-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000012/primary_doc.xml","form_type":"4"}},{"id":827125,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T21:39:47.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":5319,"price":5.4,"value":28722.6,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":532091,"source":{"system":"sec-edgar","filing":"0001835544-26-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000011/primary_doc.xml","form_type":"4"}},{"id":827124,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T21:39:47.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":7098,"price":5.5,"value":39039.0,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":537410,"source":{"system":"sec-edgar","filing":"0001835544-26-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000011/primary_doc.xml","form_type":"4"}},{"id":827123,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T21:39:47.000Z","date":"2026-03-24","kind":"sale","planned":false,"acquired":false,"shares":5492,"price":5.78,"value":31743.76,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":544508,"source":{"system":"sec-edgar","filing":"0001835544-26-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000011/primary_doc.xml","form_type":"4"}},{"id":890894,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23398,"kind":"person","name":"McLaughlin Vallerie","position":1,"cik":"0001876030","reported_name":"McLaughlin Vallerie","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:05:57.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":3030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 3,030 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":3030,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":3030},"source":{"system":"sec-edgar","filing":"0001437749-26-004913","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1876030/000143774926004913/rdgdoc.xml","form_type":"4"}},{"id":890430,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23299,"kind":"person","name":"WILCOX REED N","position":1,"cik":"0001266609","reported_name":"WILCOX REED N","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:05:22.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":3306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 3,306 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":3306,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":3306},"source":{"system":"sec-edgar","filing":"0001437749-26-004911","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266609/000143774926004911/rdgdoc.xml","form_type":"4"}},{"id":890099,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:04:47.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":4201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 4,201 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":4201,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":4201},"source":{"system":"sec-edgar","filing":"0001437749-26-004909","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926004909/rdgdoc.xml","form_type":"4"}},{"id":890428,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:04:09.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":5372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 5,372 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":5372,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":5372},"source":{"system":"sec-edgar","filing":"0001437749-26-004906","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926004906/rdgdoc.xml","form_type":"4"}},{"id":890098,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":20726,"kind":"person","name":"Desai Arjun JJ","position":1,"cik":"0001982985","reported_name":"Desai Arjun JJ","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:03:33.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":3168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 3,168 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":3168,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":3168},"source":{"system":"sec-edgar","filing":"0001437749-26-004903","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926004903/rdgdoc.xml","form_type":"4"}},{"id":890094,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23204,"kind":"person","name":"Jacobovitz Shalom","position":1,"cik":"0001835556","reported_name":"Jacobovitz Shalom","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:02:52.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":4098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 4,098 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":4098,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":4098},"source":{"system":"sec-edgar","filing":"0001437749-26-004901","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926004901/rdgdoc.xml","form_type":"4"}},{"id":890834,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23375,"kind":"person","name":"Gay Jonathon","position":1,"cik":"0001835422","reported_name":"Gay Jonathon","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:02:07.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":3271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 3,271 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":3271,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":3271},"source":{"system":"sec-edgar","filing":"0001437749-26-004899","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835422/000143774926004899/rdgdoc.xml","form_type":"4"}},{"id":890967,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23410,"kind":"person","name":"Kiernan Matthew","position":1,"cik":"0001993183","reported_name":"Kiernan Matthew","relationship":{"director":true}}],"security":"stock option","published_at":"2026-02-20T21:01:09.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":2755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 19, 2026 as an option for 2,755 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant."}],"balance_after":2755,"derivative":{"exercise_price":4.73,"expiration_date":"2036-02-18","underlying":"common stock","underlying_shares":2755},"source":{"system":"sec-edgar","filing":"0001437749-26-004897","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993183/000143774926004897/rdgdoc.xml","form_type":"4"}},{"id":917244,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T15:18:03.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":5559,"price":4.1,"value":22791.9,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":550000,"source":{"system":"sec-edgar","filing":"0001835544-26-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000010/primary_doc.xml","form_type":"4"}},{"id":924400,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-02T22:10:00.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":3800,"price":4.04,"value":15352.0,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":555559,"source":{"system":"sec-edgar","filing":"0001835544-26-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000009/primary_doc.xml","form_type":"4"}},{"id":924399,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-02T22:10:00.000Z","date":"2026-01-30","kind":"sale","planned":false,"acquired":false,"shares":5686,"price":4.13,"value":23483.18,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":559359,"source":{"system":"sec-edgar","filing":"0001835544-26-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000009/primary_doc.xml","form_type":"4"}},{"id":924398,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-02T22:10:00.000Z","date":"2026-01-29","kind":"sale","planned":false,"acquired":false,"shares":15284,"price":4.32,"value":66026.88,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":565045,"source":{"system":"sec-edgar","filing":"0001835544-26-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000009/primary_doc.xml","form_type":"4"}},{"id":928645,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T22:01:41.000Z","date":"2026-01-28","kind":"sale","planned":false,"acquired":false,"shares":8717,"price":4.91,"value":42800.47,"ownership":{"direct":false,"nature":"By SymBiosis II, LLC"},"balance_after":580329,"source":{"system":"sec-edgar","filing":"0001835544-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000008/primary_doc.xml","form_type":"4"}},{"id":928644,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T22:01:41.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4139,"price":5.08,"value":21026.12,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":589046,"source":{"system":"sec-edgar","filing":"0001835544-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000008/primary_doc.xml","form_type":"4"}},{"id":928643,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T22:01:41.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":6418,"price":5.02,"value":32218.36,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":593185,"source":{"system":"sec-edgar","filing":"0001835544-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000008/primary_doc.xml","form_type":"4"}},{"id":931901,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T22:33:41.000Z","date":"2026-01-23","kind":"sale","planned":false,"acquired":false,"shares":5556,"price":5.27,"value":29280.12,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":599603,"source":{"system":"sec-edgar","filing":"0001835544-26-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000007/primary_doc.xml","form_type":"4"}},{"id":931900,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T22:33:41.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":12665,"price":5.32,"value":67377.8,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":605159,"source":{"system":"sec-edgar","filing":"0001835544-26-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000007/primary_doc.xml","form_type":"4"}},{"id":932096,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"stock option","published_at":"2026-01-23T21:16:04.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 22, 2026 as an option for 35,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant."}],"balance_after":35000,"derivative":{"exercise_price":5.42,"expiration_date":"2036-01-21","underlying":"common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-26-001915","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000143774926001915/rdgdoc.xml","form_type":"4"}},{"id":932423,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38213,"kind":"person","name":"Mortenson Mark","position":1,"cik":"0001835427","reported_name":"Mortenson Mark","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"stock option","published_at":"2026-01-23T21:14:25.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 22, 2026 as an option for 75,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant."}],"balance_after":75000,"derivative":{"exercise_price":5.42,"expiration_date":"2036-01-21","underlying":"common stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-26-001912","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835427/000143774926001912/rdgdoc.xml","form_type":"4"}},{"id":931897,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":37998,"kind":"person","name":"Etherington Robert Dee","position":1,"cik":"0001835330","reported_name":"Etherington Robert Dee","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"stock option","published_at":"2026-01-23T21:12:12.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 22, 2026 as an option for 75,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant."}],"balance_after":75000,"derivative":{"exercise_price":5.42,"expiration_date":"2036-01-21","underlying":"common stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-26-001910","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774926001910/rdgdoc.xml","form_type":"4"}},{"id":933977,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T23:13:59.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":12119,"price":5.05,"value":61200.95,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":617824,"source":{"system":"sec-edgar","filing":"0001835544-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000006/primary_doc.xml","form_type":"4"}},{"id":933976,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T23:13:59.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":12432,"price":4.8,"value":59673.6,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":629943,"source":{"system":"sec-edgar","filing":"0001835544-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000006/primary_doc.xml","form_type":"4"}},{"id":933975,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T23:13:59.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":7923,"price":5.13,"value":40644.99,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":642375,"source":{"system":"sec-edgar","filing":"0001835544-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000006/primary_doc.xml","form_type":"4"}},{"id":936689,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T16:16:45.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":12563,"price":5.1,"value":64071.3,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":650298,"source":{"system":"sec-edgar","filing":"0001835544-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000005/primary_doc.xml","form_type":"4"}},{"id":936688,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T16:16:45.000Z","date":"2026-01-14","kind":"sale","planned":false,"acquired":false,"shares":19621,"price":5.12,"value":100459.52,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":662861,"source":{"system":"sec-edgar","filing":"0001835544-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000005/primary_doc.xml","form_type":"4"}},{"id":936687,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T16:16:45.000Z","date":"2026-01-13","kind":"sale","planned":false,"acquired":false,"shares":26105,"price":4.89,"value":127653.45,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":682482,"source":{"system":"sec-edgar","filing":"0001835544-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000005/primary_doc.xml","form_type":"4"}},{"id":939857,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (Right to buy)","published_at":"2026-01-13T23:46:50.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":46667,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The exercise price for each Series B Warrant will increase from $6.00 to $12.50 per share if: (i) the Series B Warrant is exercised prior to the Company's public announcement of its receipt of written approval from the FDA of its NDA for CNM-Au8 in ALS or (ii) the VWAP of the Company's common stock is equal to or greater than $25.00 on the associated measurement date. The exercise price of the Series B Warrant will increase to $10.00 per share if the VWAP of the Company's common stock is equal to or greater than $20.00 on the associated measurement date."},{"field":"shares","element":"transactionShares","label":"F12","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $15,596,000 by the applicable exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price of each Unit is $6.50; one Unit consists of one share of Common Stock of Clene Inc., one Series A Warrant and one Series B Warrant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F12","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $15,596,000 by the applicable exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":46667,"derivative":{"exercise_price":6,"exercise_date":"2026-01-09","expiration_date":"2029-01-09","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-26-003464","document":"tm263117-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000110465926003464/tm263117-1_4seq1.xml","form_type":"4"}},{"id":939856,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (Right to buy)","published_at":"2026-01-13T23:46:50.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The exercise price for each Series A Warrant will increase from $6.00 to $7.00 per share if either: (a) the warrant is exercised prior to the Company's public announcement of the U.S. Food and Drug Administration's (the \"FDA\") posted action date under the Prescription Drugs User Fee Act for the Company's new drug application (\"NDA\") for CNM-Au8 (the \"Series A Trigger Announcement\") or (b) the volume-weighted average price (the \"VWAP\") of the Company's common stock equals or exceeds $10.00 on the measurement date associated with the Series A Trigger Announcement."},{"field":"shares","element":"transactionShares","label":"F10","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $6,684,000 by the applicable exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price of each Unit is $6.50; one Unit consists of one share of Common Stock of Clene Inc., one Series A Warrant and one Series B Warrant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F10","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $6,684,000 by the applicable exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":20000,"derivative":{"exercise_price":6,"exercise_date":"2026-01-09","expiration_date":"2029-01-09","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-26-003464","document":"tm263117-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000110465926003464/tm263117-1_4seq1.xml","form_type":"4"}},{"id":939855,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tranche A Warrants (Right to buy)","published_at":"2026-01-13T23:46:50.000Z","date":"2026-01-09","kind":"other","planned":false,"acquired":false,"shares":57219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this line represents a distribution in kind by the limited liability company to a limited partner for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Tranche A Warrants will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the FDA accepts a New Drug Application from the Company. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":62500,"derivative":{"exercise_price":22,"exercise_date":"2023-06-16","underlying":"Common Stock","underlying_shares":57219},"source":{"system":"sec-edgar","filing":"0001104659-26-003464","document":"tm263117-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000110465926003464/tm263117-1_4seq1.xml","form_type":"4"}},{"id":939854,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tranche B Warrants (Right to buy)","published_at":"2026-01-13T23:46:50.000Z","date":"2026-01-09","kind":"other","planned":false,"acquired":false,"shares":57219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this line represents a distribution in kind by the limited liability company to a limited partner for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Tranche B Warrants will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the FDA approval of a New Drug Application from the Company. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":62500,"derivative":{"exercise_price":30,"exercise_date":"2023-06-16","underlying":"Common Stock","underlying_shares":57219},"source":{"system":"sec-edgar","filing":"0001104659-26-003464","document":"tm263117-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000110465926003464/tm263117-1_4seq1.xml","form_type":"4"}},{"id":939853,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T23:46:50.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":6,"value":100002.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Kensington Clene 2021, LLC entered into a Securities Purchase Agreement with Clene Inc. and the other parties thereto, dated January 8, 2026, for the purchase of 16,667 shares of the Company's common stock, Series A Warrants to purchase 20,000 shares of the Company's common Stock and Series B Warrants to purchase 46,667 shares of the Company's common stock, closing effective January 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price of each Unit is $6.50; one Unit consists of one share of Common Stock of Clene Inc., one Series A Warrant and one Series B Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":280500,"source":{"system":"sec-edgar","filing":"0001104659-26-003464","document":"tm263117-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000110465926003464/tm263117-1_4seq1.xml","form_type":"4"}},{"id":939852,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23205,"kind":"person","name":"Mosca Alison","position":1,"cik":"0001835537","reported_name":"Mosca Alison","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T23:46:50.000Z","date":"2026-01-09","kind":"other","planned":false,"acquired":false,"shares":57219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this line represents a distribution in kind by the limited liability company to a limited partner for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest."}],"balance_after":263833,"source":{"system":"sec-edgar","filing":"0001104659-26-003464","document":"tm263117-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000110465926003464/tm263117-1_4seq1.xml","form_type":"4"}},{"id":939968,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2026-01-13T19:48:54.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":93333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price for each Series B Warrant will increase from $6.00 to $12.50 per share if: (i) the Series B Warrant is exercised prior to the Company's public announcement of its receipt of written approval from the FDA of its NDA for CNM-Au8 in ALS or (ii) the VWAP of the Company's common stock is equal to or greater than $25.00 on the associated measurement date. The exercise price of the Series B Warrant will increase to $10.00 per share if the VWAP of the Company's common stock is equal to or greater than $20.00 on the associated measurement date."},{"field":"shares","element":"transactionShares","label":"F6","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $15,596,000 by the applicable exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price of each Unit is $6.50 consisting of one share of Common Stock of Clene, one Series A Warrant and one Series B Warrant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $15,596,000 by the applicable exercise price."}],"balance_after":93333,"derivative":{"exercise_price":6,"exercise_date":"2026-01-13","expiration_date":"2031-01-13","underlying":"common stock"},"source":{"system":"sec-edgar","filing":"0001437749-26-001170","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926001170/rdgdoc.xml","form_type":"4"}},{"id":939967,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2026-01-13T19:48:54.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of each Series A Warrant will increase from $6.00 to $7.00 per share if either: (a) the warrant is exercised prior to the Company's public announcement of the U.S. Food and Drug Administration's (the \"FDA\") posted action date under the Prescription Drug User Fee Act for the Company's new drug application (\"NDA\") for CNM-Au8 (the \"Series A Trigger Announcement \"); or (b) the volume-weighted average price (the \"VWAP\") of the Company's common stock equals or exceeds $10.00 on the measurement date associated with the Series A Trigger Announcement."},{"field":"shares","element":"transactionShares","label":"F4","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $6,684,000 by the applicable exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price of each Unit is $6.50 consisting of one share of Common Stock of Clene, one Series A Warrant and one Series B Warrant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $6,684,000 by the applicable exercise price."}],"balance_after":40000,"derivative":{"exercise_price":6,"exercise_date":"2026-01-13","expiration_date":"2029-01-13","underlying":"common stock"},"source":{"system":"sec-edgar","filing":"0001437749-26-001170","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926001170/rdgdoc.xml","form_type":"4"}},{"id":939966,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":23297,"kind":"person","name":"MATLIN DAVID J","position":1,"cik":"0001251956","reported_name":"MATLIN DAVID J","relationship":{"director":true}}],"security":"common stock","published_at":"2026-01-13T19:48:54.000Z","date":"2026-01-13","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":6.5,"value":216664.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with Clene Inc. and the other parties thereto, dated January 8, 2026, for the purchase of 33,333 shares of the Company's common stock, Series A Warrants to purchase 40,000 shares of the Company's common stock and Series B Warrants to purchase 93,333 shares of the Company's common stock, closing effective January 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price of each Unit is $6.50 consisting of one share of Common Stock of Clene, one Series A Warrant and one Series B Warrant."}],"balance_after":477824,"source":{"system":"sec-edgar","filing":"0001437749-26-001170","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251956/000143774926001170/rdgdoc.xml","form_type":"4"}},{"id":940677,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-12T21:38:18.000Z","date":"2026-01-12","kind":"sale","planned":false,"acquired":false,"shares":32705,"price":5.5,"value":179877.5,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":708587,"source":{"system":"sec-edgar","filing":"0001835544-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000003/primary_doc.xml","form_type":"4"}},{"id":940676,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-12T21:38:18.000Z","date":"2026-01-09","kind":"sale","planned":false,"acquired":false,"shares":9075,"price":6.27,"value":56900.25,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":741292,"source":{"system":"sec-edgar","filing":"0001835544-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000003/primary_doc.xml","form_type":"4"}},{"id":940675,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-12T21:38:18.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":3195,"price":6.09,"value":19457.55,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":750367,"source":{"system":"sec-edgar","filing":"0001835544-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000003/primary_doc.xml","form_type":"4"}},{"id":943877,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:28:09.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":3938,"price":6.29,"value":24770.02,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":753562,"source":{"system":"sec-edgar","filing":"0001835544-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000002/primary_doc.xml","form_type":"4"}},{"id":943876,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:28:09.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":3111,"price":6.04,"value":18790.44,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":757500,"source":{"system":"sec-edgar","filing":"0001835544-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000002/primary_doc.xml","form_type":"4"}},{"id":943875,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:28:09.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":5869,"price":5.87,"value":34451.03,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":760611,"source":{"system":"sec-edgar","filing":"0001835544-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000002/primary_doc.xml","form_type":"4"}},{"id":954817,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:25:57.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":4015,"price":5.73,"value":23005.95,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":766480,"source":{"system":"sec-edgar","filing":"0001835544-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000001/primary_doc.xml","form_type":"4"}},{"id":954816,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:25:57.000Z","date":"2025-12-31","kind":"sale","planned":false,"acquired":false,"shares":13095,"price":5.81,"value":76081.95,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":770495,"source":{"system":"sec-edgar","filing":"0001835544-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554426000001/primary_doc.xml","form_type":"4"}},{"id":956283,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T17:10:37.000Z","date":"2025-12-30","kind":"sale","planned":false,"acquired":false,"shares":4138,"price":6.03,"value":24952.14,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":783590,"source":{"system":"sec-edgar","filing":"0001835544-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554425000006/primary_doc.xml","form_type":"4"}},{"id":956282,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T17:10:37.000Z","date":"2025-12-29","kind":"sale","planned":false,"acquired":false,"shares":8096,"price":5.95,"value":48171.2,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":787728,"source":{"system":"sec-edgar","filing":"0001835544-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554425000006/primary_doc.xml","form_type":"4"}},{"id":956948,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant to Purchase Common Stock","published_at":"2025-12-31T02:03:22.000Z","date":"2025-12-23","kind":"other","planned":false,"acquired":false,"shares":424358,"price":4.587,"value":1946530.146,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The pre-funded warrants are indefinite with no specified termination date."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2024-10-01","underlying":"Common Stock","underlying_shares":424358},"source":{"system":"sec-edgar","filing":"0001835544-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554425000005/primary_doc.xml","form_type":"4"}},{"id":956947,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T02:03:22.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":3350,"price":6.32,"value":21172.0,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":795824,"source":{"system":"sec-edgar","filing":"0001835544-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554425000005/primary_doc.xml","form_type":"4"}},{"id":956946,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":19352,"kind":"person","name":"Ugwumba Chidozie","position":1,"cik":"0001835544","reported_name":"Ugwumba Chidozie","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T02:03:22.000Z","date":"2025-12-24","kind":"sale","planned":false,"acquired":false,"shares":1490,"price":6.27,"value":9342.3,"ownership":{"direct":false,"nature":"By Symbiosis II, LLC"},"balance_after":799174,"source":{"system":"sec-edgar","filing":"0001835544-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822791/000183554425000005/primary_doc.xml","form_type":"4"}}],"next_cursor":"2025-12-31T02:03:22.000000Z,956946"}